Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model.
Mottram
P L
PL
Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
Pietersz
G A
GA
Purcell
L J
LJ
Krauer
K
K
Clunie
G J
GJ
McKenzie
I F
IF
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D000950:Antigens, Ly / Q000276:immunology*; D016827:CD8 Antigens; D005434:Flow Cytometry; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D015255:Idarubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D008198:Lymph Nodes / Q000276:immunology; D008212:Lymphocyte Depletion; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D013154:Spleen / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000950:Antigens, Ly; D016827:CD8 Antigens; D015255:Idarubicin